|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM319404293 |
003 |
DE-627 |
005 |
20231225171357.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2020 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.15844/pedneurbriefs-34-25
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1064.xml
|
035 |
|
|
|a (DE-627)NLM319404293
|
035 |
|
|
|a (NLM)33376294
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Ganesh, Abhinaya
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Safety and Efficacy of Cannabis in Autism Spectrum Disorder
|
264 |
|
1 |
|c 2020
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Revised 31.12.2020
|
500 |
|
|
|a published: Electronic
|
500 |
|
|
|a CommentOn: Sci Rep. 2019 Jan 17;9(1):200. - PMID 30655581
|
500 |
|
|
|a Citation Status PubMed-not-MEDLINE
|
520 |
|
|
|a Copyright: © 2020 The Author(s).
|
520 |
|
|
|a Investigators from the Soroka University Medical Centre, The Hebrew University of Jerusalem, and Tikun Olam Ltd. in Israel studied the safety and efficacy of medical cannabis treatment on 188 patients with autism spectrum disorder (ASD) for six months
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Comment
|
650 |
|
4 |
|a ASD
|
650 |
|
4 |
|a Autism
|
650 |
|
4 |
|a CBD
|
650 |
|
4 |
|a Cannabidiol
|
650 |
|
4 |
|a Cannabis
|
650 |
|
4 |
|a Neurodevelopment
|
650 |
|
4 |
|a Neurology
|
650 |
|
4 |
|a Pediatrics
|
650 |
|
4 |
|a THC
|
700 |
1 |
|
|a Shareef, Safiullah
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Pediatric neurology briefs
|d 1997
|g 34(2020) vom: 24. Dez., Seite 25
|w (DE-627)NLM098248251
|x 1043-3155
|7 nnns
|
773 |
1 |
8 |
|g volume:34
|g year:2020
|g day:24
|g month:12
|g pages:25
|
856 |
4 |
0 |
|u http://dx.doi.org/10.15844/pedneurbriefs-34-25
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 34
|j 2020
|b 24
|c 12
|h 25
|